Rosetta Genomics Interpace Diagnostics Q3 Revenues Up 38 Percent The company beat the consensus Wall Street estimate on the top line and guided to 2018 revenues of between $21 million and $22 million. Rosetta Genomics Files for Chapter 7 Bankruptcy Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned. Rosetta Genomics Dispute With Genoptix Places Pending Merger in Jeopardy The merger, which was previously scuttled and later revived with Rosetta shareholder approval, was due to close on May 27. Rosetta Genomics Shareholders Approve Genoptix Merger Upon completion of the transaction, Rosetta will become a privately held subsidiary of Genoptix and its shares will cease to trade on the Nasdaq. Genoptix Inks Distribution Deal for Rosetta Genomics' Testing Services The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders. Feb 28, 2018 Rosetta Genomics, Genoptix Sign New Merger Agreement Feb 23, 2018 Rosetta Genomics, Genoptix Merger Terminated Dec 15, 2017 Genoptix to Acquire Rosetta Genomics for $10M Nov 30, 2017 Rosetta Genomics Receives Nasdaq Non-Compliance Letter Nov 8, 2017 Rosetta Genomics Receives Notification of Nasdaq Non-Compliance Oct 10, 2017 Rosetta Genomics Q2 Revenues Jump on Sales of Thyroid Assay Sep 28, 2017 Rosetta Genomics Initiates $2M Private Placement Sep 8, 2017 Rosetta Genomics Inks Deal to Sell PersonalizeDx for $2.9M Sep 5, 2017 Rosetta Genomics Announces Layoffs Aug 4, 2017 Rosetta Genomics Prices $2.7M Securities Offering May 23, 2017 Rosetta Genomics, Meir Medical Partner on microRNA Biomarker Study May 22, 2017 Rosetta Genomics Plans to Sell PersonalizeDx Business May 5, 2017 Rosetta Genomics Signs Brazilian Distribution Pact for Thyroid Test May 4, 2017 NYS Gives Final Approval for Rosetta Genomics' Thyroid Cancer Test May 2, 2017 Rosetta Genomics Realigns Strategy to Focus on Thyroid Test Mar 30, 2017 Rosetta Genomics Q4 Revenues Drop 44 Percent Mar 16, 2017 Rosetta Genomics Announces Reverse Stock Split Feb 23, 2017 Rosetta Genomics Completes Private Placement Tranche Feb 8, 2017 Rosetta Genomics Reports Q4 Sales Growth for Thyroid Nodule Test Dec 20, 2016 Rosetta Genomics Q3 Revenues Down 10 Percent Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.